| Comparative effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) vaccines in preventing COVID-19 hospitalizations among adults without immunocompromising … WH Self MMWR. Morbidity and mortality weekly report 70, 2021 | 459 | 2021 |
| Waning 2-dose and 3-dose effectiveness of mRNA vaccines against COVID-19–associated emergency department and urgent care encounters and hospitalizations among adults during … JM Ferdinands MMWR. Morbidity and mortality weekly report 71, 2022 | 438 | 2022 |
| Effectiveness of a third dose of mRNA vaccines against COVID-19–associated emergency department and urgent care encounters and hospitalizations among adults during periods of … MG Thompson MMWR. Morbidity and mortality weekly report 71, 2022 | 437 | 2022 |
| Influenza vaccine effectiveness in the United States during 2012–2013: variable protection by age and virus type HQ McLean, MG Thompson, ME Sundaram, BA Kieke, M Gaglani, ... The Journal of infectious diseases 211 (10), 1529-1540, 2015 | 319 | 2015 |
| Influenza vaccine effectiveness in the United States during the 2015–2016 season ML Jackson, JR Chung, LA Jackson, CH Phillips, J Benoit, AS Monto, ... New England Journal of Medicine 377 (6), 534-543, 2017 | 309 | 2017 |
| 2014–2015 influenza vaccine effectiveness in the United States by vaccine type RK Zimmerman, MP Nowalk, J Chung, ML Jackson, LA Jackson, ... Clinical Infectious Diseases, ciw635, 2016 | 279 | 2016 |
| Sustained effectiveness of Pfizer-BioNTech and Moderna vaccines against COVID-19 associated hospitalizations among adults—United States, March–July 2021 MW Tenforde MMWR. Morbidity and mortality weekly report 70, 2021 | 249 | 2021 |
| Interim estimates of 2017–18 seasonal influenza vaccine effectiveness—United States, February 2018 B Flannery MMWR. Morbidity and mortality weekly report 67, 2018 | 214 | 2018 |
| Influenza vaccine effectiveness against 2009 pandemic influenza A (H1N1) virus differed by vaccine type during 2013–2014 in the United States M Gaglani, J Pruszynski, K Murthy, L Clipper, A Robertson, M Reis, ... The Journal of infectious diseases 213 (10), 1546-1556, 2016 | 194 | 2016 |
| Outpatient antibiotic prescribing for acute respiratory infections during influenza seasons FP Havers, LA Hicks, JR Chung, M Gaglani, K Murthy, RK Zimmerman, ... JAMA network open 1 (2), e180243-e180243, 2018 | 193 | 2018 |
| Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA vaccination in preventing COVID-19–associated emergency department and urgent care encounters and hospitalizations among … NP Klein MMWR. Morbidity and mortality weekly report 71, 2022 | 183 | 2022 |
| Effectiveness of 2-dose vaccination with mRNA COVID-19 vaccines against COVID-19–associated hospitalizations among immunocompromised adults—nine states, January–September 2021 PJ Embi MMWR. Morbidity and Mortality Weekly Report 70, 2021 | 170 | 2021 |
| Early estimates of bivalent mRNA vaccine effectiveness in preventing COVID-19–associated emergency department or urgent care encounters and hospitalizations among … MW Tenforde MMWR. Morbidity and mortality weekly report 71, 2022 | 129 | 2022 |
| Laboratory-confirmed COVID-19 among adults hospitalized with COVID-19–like illness with infection-induced or mRNA vaccine-induced SARS-CoV-2 immunity—nine states, January … CH Bozio MMWR. Morbidity and Mortality Weekly Report 70, 2021 | 126 | 2021 |
| Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control study JM Ferdinands, S Rao, BE Dixon, PK Mitchell, MB DeSilva, SA Irving, ... bmj 379, 2022 | 125 | 2022 |
| Interim estimates of 2016–17 seasonal influenza vaccine effectiveness—United States, February 2017 B Flannery MMWR. Morbidity and mortality weekly report 66, 2017 | 121 | 2017 |
| Seasonal effectiveness of live attenuated and inactivated influenza vaccine JR Chung, B Flannery, MG Thompson, M Gaglani, ML Jackson, AS Monto, ... Pediatrics 137 (2), 2016 | 113 | 2016 |
| Influenza vaccine effectiveness in the United States during the 2016–2017 season B Flannery, JR Chung, AS Monto, ET Martin, EA Belongia, HQ McLean, ... Clinical Infectious Diseases 68 (11), 1798-1806, 2019 | 107 | 2019 |
| Effectiveness of 2, 3, and 4 COVID-19 mRNA vaccine doses among immunocompetent adults during periods when SARS-CoV-2 Omicron BA. 1 and BA. 2/BA. 2.12. 1 sublineages … R Link-Gelles MMWR. Morbidity and mortality weekly report 71, 2022 | 106 | 2022 |
| Interim adjusted estimates of seasonal influenza vaccine effectiveness—United States, February 2013 L Jackson, ML Jackson, CH Phillips, J Benoit, EA Belongia, D Cole, ... Morbidity and Mortality Weekly Report 62 (7), 119, 2013 | 99 | 2013 |
